Case Report

Neuroendocrine tumor of the gastrointestinal: report of two cases

Made Agus Dwianthara Sueta , Made Oka Sastrawan

Made Agus Dwianthara Sueta
Digestive Surgery Division, Surgery Department of Faculty of Medicine Udayana University, Sanglah General Hospital Denpasar, Bali-Indonesia. Email: dwiantharasuetaagus@gmail.com

Made Oka Sastrawan
Surgical Resident, Surgery Department of Faculty of Medicine Udayana University, Sanglah General Hospital Denpasar, Bali-Indonesia
Online First: August 01, 2019 | Cite this Article
Dwianthara Sueta, M., Sastrawan, M. 2019. Neuroendocrine tumor of the gastrointestinal: report of two cases. Intisari Sains Medis 10(2). DOI:10.15562/ism.v10i2.409


Introduction: Neuroendocrine tumors are malignancies that need special attention because they provide clinical manifestations that are not typical of excess gastrointestinal endocrine production. Case reports of neuroendocrine tumors are needed to be able to recognize the symptoms and determine the appropriate therapy.

Case series: The first patient was 49 years old Balinese female, consulted from internist with right lower-quadrant tenderness with fever for three days before. The patient also had diarrhea for one week before. The patient has done an appendectomy, and the pathological result of the appendix specimen was Neuroendocrine Appendix. The second patient was 62 years old Balinese male, complained about intermittent diarrhea for two months. Patient has done laparotomy exploration and colostomy because of a transverse colon tumor. The pathological result of the specimen from transverse colon tumor was mixed adeno-neuroendocrine carcinoma. Both patients have been treating with hormonal therapy (somatostatin analogs) long-acting release (LAR); the second patient also had combined with folfox IV chemotherapy.

Conclusion: The choice of therapy with somatostatin analogs in the first case and surgery in the second case gave a good response after treatment. However, in both cases, it does not guarantee the cure of this disease.

 

References

Toole DO., Kianmanesh R., Caplin M. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update. Neuroendocrinology. 2016;103:117–118.

Castaño JP., Sundin A., Maecke HR., Villabona C., Vazquez-Albertino R., Navarro E., Oberg K. Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenge. Cancer Metastasis Rev. 2014;33(1):353-9.

Narayanan, S., Kunz PL. Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Hematol Oncol Clin N Am. 2016;30:163–177.

Griniatsos J., Michail O. 2014. Appendiceal neuroendocrine tumors: Recent insight and clinical implications. World Journal of Gastrointestinal Oncology. 2014;2:192-196.

Moosavy, SH., Andrabi Y., Esmaeeli S., Amini A. Small bowel obstruction by a terminal ileum carcinoid tumor: a case report. Medical Journal of Islamic Republic of Iran. 2011;25(3):165-169.

Xenaki S., Lasithiotakis K., Andreou A., Aggelaki S., Tzardi M., Daskalaki A., Chalkiadakis G., Chrysos E. Case report: A Rare Case of Mixed Neuroendocrine Tumor and Adenocarcinoma of the Pancreas. Case Reports in Surgery. 2016;2016:1-4.

Prasad ND., Manmadharao V., Babji K., Reddy DK. Intestinal Obstruction by Carcinoid Tumor in Ileum: A Case Report. International Journal of Scientific Study. 2015;2(10):166-168.

Uccella S., Sessa F., La Rosa S. Diagnostic Approach to Neuroendocrine Neoplasm of Gastrointestinal Tract and Pancreas. Turk Patoloji Derg 2015;31(Suppl):113-127.

Padhi S., Sahoo B., Meher P., Besra K., Samantaray S. Neuroendocrine Tumors – A Case Series and Literature Review. International Journal of Medical Research and Pharmaceutical Sciences. 2017;4(2):11-17.

Kim JY., Hong SM. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Arch Pathol Lab Med. 2016;140:437-448.

Kumar U., Michael G. Somatostatin and Somatostatin Receptors. Result and problems in cell differentiation. 2009;50:137-84.

Wolin EM. The Expanding Role of Somatostatin Analogs in the Management of Neuroendocrine Tumors. Gastrointest Cancer Res.2102;5:161-168.

Saclarides TJ., Szeluga D., Staren ED. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Dis Colon Rectum. 1994;37(7):635-42

Ruszniewski P., Ish-Shalom S., Wymenga M., O'Toole D., Arnold R., Tomassetti P., Bax N., Caplin M., Eriksson B., Glaser B., et al. Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology. 2004;80:244–251.

M Indrayani LPI., Sriwidnyani NP. K-RAS mutation profile in colorectal carcinoma patients in Sanglah Hospital Denpasar, Bali-Indonesia. Bali Med J. 2017;3(3):S40-S42 doi: 10.15562/bmj.v3i3.717.


Article Views      : 351
PDF Downloads : 22